Managed health care company Magellan Health, Inc., a subsidiary of Centene (NYSE:CNC), announced on Thursday that it has introduced a Teen Mental Wellbeing app aimed at supporting individuals aged 13-22.
Powered by BeMe Health's digital platform, the app offers evidence-based tools to enhance self-awareness, resilience and mental health.
Designed for use on mobile devices, it provides real-time content tailored to users' moods, skill-building activities and personalized coaching via chat. Clinically validated screenings, including for depression and anxiety, help triage participants to appropriate interventions.
Users have 24/7 access to crisis support and can be referred to virtual therapy sessions through Magellan's employee assistance program.
Johnson & Johnson agrees acquisition of V-Wave
Nightingale Health gains UKCA certification and expands with new laboratory
Talphera enrols first subject in NEPHRO CRRT study
China Pharma Holdings anticipates launch of Dry Eye Disease Therapeutic Device in early 2025
SOPHiA DDM Platform achieves IVDR certification, enhancing diagnostic precision
Medtronic reports FDA approval of Simplera CGM; partners with Abbott
OncoBeta expands Rhenium-SCT (Skin Cancer Therapy) treatment services in Italy
Labcorp's PGDx elio plasma focus Dx receives US FDA De Novo marketing authorisation
Verici Dx announces completion of Thermo Fisher Scientific licensing agreement
Polarean Imaging enters into trade-in agreement with University of Kansas Medical Center